NCT07038876 - A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

June 27, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions

Schizophrenia

Interventions

DRUG

Placebo

Matched Placebo

DRUG

ML-007C-MA BID

ML-007C-MA dosed as 210/3 mg BID

DRUG

ML-007C-MA QD

ML-007C-MA dosed as 330/6 mg QD

Trial Locations (25)

10314

RECRUITING

Clinical Site, Staten Island

30030

RECRUITING

Clinical Site, Decatur

30331

RECRUITING

Clinical Site, Atlanta

33016

RECRUITING

Clinical Site, Miami Lakes

33024

RECRUITING

Clinical Site, Hollywood

33407

RECRUITING

Clinical Site, West Palm Beach

44720

RECRUITING

Clinical Site, North Canton

60640

RECRUITING

Clinical Site, Chicago

72211

RECRUITING

Clinical Site, Little Rock

75080

RECRUITING

Clinical Site, Richardson

75115

RECRUITING

Clinical Site, DeSoto

78754

RECRUITING

Clinical Site, Austin

90015

RECRUITING

Clinical Site, Los Angeles

90230

RECRUITING

Clinical Site, Culver City

90504

RECRUITING

Clinical Site, Torrance

90706

RECRUITING

Clinical Site, Bellflower

91403

RECRUITING

Clinical Site, Sherman Oaks

91763

RECRUITING

Clinical Site, Montclair

91945

RECRUITING

Clinical Site, Lemon Grove

92071

RECRUITING

Clinical Site, Santee

92123

RECRUITING

Clinical Site, San Diego

92506

RECRUITING

Clinical Site, Riverside

92845

RECRUITING

Clinical Site, Garden Grove

92868

RECRUITING

Clinical Site, Orange

08053

RECRUITING

Clinical Site, Marlton